Financials data is unavailable for this security.
View more
Year on year Evome Medical Technologies Inc grew revenues 86.42% from 33.59m to 62.63m while net income improved from a loss of 15.90m to a smaller loss of 15.60m.
Gross margin | 34.58% |
---|---|
Net profit margin | -33.45% |
Operating margin | -36.25% |
Return on assets | -35.78% |
---|---|
Return on equity | -289.79% |
Return on investment | -144.36% |
More ▼
Cash flow in CADView more
In 2023, cash reserves at Evome Medical Technologies Inc fell by 1.01m. Cash Flow from Financing totalled 824.54k or 1.32% of revenues. In addition the company used 918.91k for operations while cash used for investing totalled 1.52m.
Cash flow per share | -0.1722 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0279 |
---|---|
Tangible book value per share | -0.119 |
More ▼
Balance sheet in CADView more
Current ratio | 0.5486 |
---|---|
Quick ratio | 0.2596 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 1.14 |
More ▼